MetaCap

Bluejay Diagnostics (BJDX) vs IceCure Medical (ICCM)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.

Summary

IceCure Medical is the larger company by market cap ($5.3 million vs $3.6 million), about 1.5 times the size.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

BJDX+0.68%ICCM-1.74%
+1%-1%-2%
Oct 7, 20261 yearOct 8, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

BJDX versus ICCM key metrics
MetricBJDXICCM
Share price$0.8146$1.15
Market cap$3.64M$5.33M
1-day change-0.12%+1.32%
EPS (TTM)$-3.58$-6.84
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
52-week high$15.12$29.46
52-week low$0.755$1.04
Distance from 52-week high-94.61%-96.10%
Analyst consensus—none
Avg. price target upside—+1871.30%
Average volume3.61M139.00K
Shares outstanding4.47M4.64M
Employees667
SectorHealth CareHealth Care
IndustryMedical/Dental InstrumentsMedical/Dental Instruments

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

About Bluejay Diagnostics

BJDX stock →

Bluejay Diagnostics, Inc. operates as a medical diagnostics company.

Health Care · Medical/Dental Instruments · 6 employees

About IceCure Medical

ICCM stock →

IceCure Medical Ltd, a commercial-stage medical device company, engages in the research, development, and marketing of cryoablation systems, disposables, and technologies for treating tumors in the United States, Japan, India, China, Israel, and internationally. The company offers the ProSense system, a single probe cryoablation system for the treatment of malignant breast tumors, as well as its associated disposables, including CryoProbes needles, and guiding needles/introducers; and IceSense3 system for ablation indications in urology, oncology, dermatology, gynecology, general surgery, thoracic surgery, and proctology.

Health Care · Medical/Dental Instruments · 67 employees

BJDX vs ICCM FAQ

Which is bigger, Bluejay Diagnostics or IceCure Medical?

IceCure Medical (ICCM) is larger, with a market capitalization of $5.33M compared with $3.64M for Bluejay Diagnostics (BJDX).

Are Bluejay Diagnostics and IceCure Medical in the same industry?

Yes. Both are classified in the Medical/Dental Instruments industry within the Health Care sector.

More comparisons